We are excited to launch Rezo, following a successful Series A, to advance a pipeline of precision therapeutics based on our groundbreaking platform that maps disease-causing networks. Learn more about Rezo here: bit.ly/3UQXZGu

I am proud to announce Rezo Therapeutics Rezo Therapeutics, co-founded with QBI PIs Kevan Shokat Sourav Bandyopadhyay and Natalia Jura. The company will develop precision therapeutics by leveraging an integrative suite of quantitative technologies developed at QBI. bit.ly/3UQXZGu

PIs at QBI Krogan Lab Kevan Shokat Sourav Bandyopadhyay Natalia Jura co-found Rezo Rezo Therapeutics, a biotech company focused on developing precision therapeutics through the integrative mapping of disease networks, inspired by the QBI mission to break down silos in science. bit.ly/3UQXZGu

Rezo Therapeutics' quarterbacks Nevan Krogan Krogan Lab and Keelan Guiley are on hand at Levi's stadium today to "assist" coach the San Francisco San Francisco 49ers

We are pleased to announce our co-founder and CEO Nevan Krogan, Ph.D., will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 8:30 a.m. PT. Be sure to attend if you’re at this year’s conference! #JPM23

What a first few months at Rezo Therapeutics building a great team and w/exhilarating science! We are looking for a CRISPR screening technical expert to lead our functional genomics group and build genetic interaction maps for cancer! Is that you? Come join us! jobs.lever.co/rezotx/72be160…

Co-founder and CEO Nevan Krogan, Ph.D., sat down with STAT reporter Allison DeAngelis at this year’s J.P. Morgan Healthcare Conference to discuss the creation and launch of Rezo. Read the full article here: bit.ly/3WPWjxv

Thrilled to have legendary CEO George Scangos at Rezo as our Board Chair. An amazing wealth of knowledge spanning every stage of biotech sourced from Biogen, Exelixis and Vir. Thanks for the shout out George! statnews.com/2023/01/26/pod…

Rezo Therapeutics congratulates Co-Founder Dr. Kevan Shokat on receiving this year’s Sjöberg Prize. Thank you, Kevan, for inspiring scientists and bringing hope to patients. Read more here:kva.se/en/prizes/sjob…

We're excited to welcome Nadir Mahmood, Ph.D., as CEO and board member! His expertise will play a pivotal role as we seek to shift the way we understand disease biology through our integrated mapping of disease networks for precision therapeutics. businesswire.com/news/home/2023…

Thank you Max Bayer and FierceBiotech for the great piece highlighting the addition of Nadir Mahmood, Ph.D., as our CEO. Hear what he and Rezo co-founder and president Nevan Krogan, Ph.D., had to say about the future of our approach here: fiercebiotech.com/biotech/ex-nka…

We're proud to share the publication of new research findings today by QBI, which emphasize how an integrated approach to drug discovery through leveraging multiple technologies and tools can be applied across disease areas. Read more here: biorxiv.org/content/10.110…

Rezo is excited to be included among BioSpace's NextGen Class of 2024! 2023 was an important year for Rezo and we look forward to carrying that same momentum into the new year as we seek to unlock a new era of #drugdiscovery. biospace.com/article/nextge…